SupremeCourt

  • Subscribe to our RSS feed.
  • Twitter
  • StumbleUpon
  • Reddit
  • Facebook
  • Digg

Sunday, May 26, 2013

Comparative Advertising: Delhi HC (Reckitt Benckiser v. Hindustan Lever Limited)

Posted on 7:59 PM by Unknown
Hindustan Lever Limited(HUL) aired a television commercial which depicted a child being sick because of the alleged use of Dettol as an antiseptic liquid in bathing water whilst promoting the superiority of Hindustan Lever Limited’s Lifebuoy Soap. The plaintiff, Reckitt Benckiser filed a suit for an ad interim injunction against the telecast of the television commercial of defendant Hindustan Lever Limited’s Lifebuoy Soap, which was disparaging and denigrating the reputation and goodwill of the plaintiff's product Dettol in the commercial market.  

Justice Kailash Gambhir of the Delhi High Court decided that the commercial telecast by the respondent indeed disparaged the product of the plaintiff and granted an interim injunction to the plaintiff against the telecast( for order read here).

The plaintiff’s primary grievance was with regard to the content of the advertisement that allegedly depicted the following: The plaintiff’s product was completely ineffective in warding off germs and emphasised that lifebuoy gives 100% germ protection. The TVC showed liquid of the same colour being poured from a bottle similar in shape to a Dettol bottle, producing a milky effect. Moreover, the language used by the father of the sick child in the advertisement emphasised on “nahane ke paani mein ‘do dhakkan’ antiseptic liquid” – a clear indication towards Dettol. These features were claimed by the plaintiff as exclusive features of the product. The disclaimer added was rather vague and blurred. 

The defendants refuted the claims by submitting that shape and colour of the bottle shown in the impugned advertisement were different from that of the plaintiff’s product. Furthermore, plaintiffs can’t claim exclusivity over the milky effect, as a huge number of products are capable of effecting the same. The advertisement also carried the disclaimer that “Graphic visualization does not represent any branded antiseptic liquid in the market. Characteristic of generic antiseptic liquid.” 

The plaintiff filed the case on three principle grounds: (i) the advertisement was against the public interest, (ii) generic disparagement of all the antiseptic liquids of which the plaintiff has 85% market share, finally (iii) disparagement of the plaintiff’s Dettol antiseptic liquid. The plaintiff also drew attention to a South African court order directing HUL to withdraw the same advertisement aired on South African television. 


Whether the advertisements were disparaging – 


The Judge after analysing a number of leading cases[1] on the law of disparagement summarized them into the following principles: 

a) A tradesman is entitled to declare his goods to be the best in the world, even though the declaration is untrue. 

b) He can state that his goods are better than his competitors. 

c) He can even compare the advantages of the two goods. He, however, cannot, while saying that his goods are better than his competitor’s, say that his competitor’s goods are bad. If he says so, he really slanders the goods of his competitors and their goods, which is not permissible in law. 

e) If there is no defamation to the goods or the manufacture of such goods no action lies, but if there is such defamation, an action lies for recovery of damages for defamation, then the court is also competent to grant an order of injunction restraining them to perform such acts. 

Further, in order to satisfy the test of comparative disparagement, the plaintiff has to establish the following key elements: 

a) A false or misleading statement of fact has been made about his product; 

b) That the statement is deceiving or has the potential to deceive, the substantial segment of prospective consumer and; 

c) The deception is likely to influence consumer’s purchasing decisions. The court has to also bear in mind while deciding whether the displayed commercial is disparaging or not, the intent of the advertisement, its manner and the effect of the telecast of such a television commercial. The manner in which the same is telecasted is of prime importance, the same should not be in the manner to ridicule or condemn the product of the competitor, resulting in disparagement or disrupting them in the market. 

The Court held that the advertisement can be viewed in two parts: One part is where as the advertisement begins, it showing display of a few toys with the sick child which is a similar aspect to that of the plaintiff‟s advertisement. The other part is the “two dhakkans” of liquid is shown as being harmful and ineffective, which as per the visualisation of the television commercial, does lay an adverse connotation and a lady pouring a brown liquid in the bucket, in the same manner and display as that of the plaintiff‟s television commercial and where the defendant's product is shown as having the qualities of providing a 100 % germ protection. There can be no grievance in respect where the qualities of the defendant's soap are sought to be demonstrated: whether those qualities exist or not is not an issue. That part, even if untrue, would be mere puffery. However, the part of the advertisement, where the antiseptic liquid has been slighted and shown in bad light and in fact, as something which is ineffective, can be construed as disparagement and denigration of the antiseptic liquid shown in the advertisement. It is one thing to say that a person's product is the best or that his product is better than somebody else's product, but, it is entirely a different matter to say that his product is good whereas another's product is bad and harmful. 

If it were a case of mere promotion of superiority of the defendant's product, alone, the plaintiff would not have had a case as that would have only betokened a permissible "better" or "best" statement. The advertisement comprises of two parts; one which denigrates and disparages the product of the plaintiff and the other which promotes the purported superiority of defendant's Lifebuoy soap. There is thus a hint of some malice involved in the commercial in respect of the defendant’s product - indeed, it would be appropriate to delete certain relevant attributes of the defendant’s advertisement which clearly hits on the plaintiff’s product and portrays the same in bad light. 


The Court granted the plaintiffs an ad-interim injunction. 


It has allowed the defendant to air the advertisement only after making the following changes to it: 

(a)Removal of ‘toys’ in the advertisement. 

(b)Removal of the phrase “two dhakkans” and the particular portion featuring the lady showing pouring liquid in the bucket by holding the bottle of the antiseptic liquid in her hand. 

(c)Removal of the shot showing the cloud formation. 

(d) Since green is the colour majorly associated with ‘Dettol’, therefore to also change the colour scheme showing the comparison between the two products in the television commercial and change the green colour to a different shade. 

[1] Reckitt & Colman of India Ltd. v. Kiwi T.T.K. Ltd.; Pepsi Co. Inc. and Ors Vs. Hindustan Coca Cola Ltd.; Godrej Consumer Products Limited Vs. Initiative Media Advertising and Another; Colgate Palmolive (India) Limited V. Anchor Health & Beauty Care Pvt. Ltd.; Imperial Tobacco Co.v. Albert Bonnan

Email ThisBlogThis!Share to XShare to FacebookShare to Pinterest
Posted in Comparative Advertising, Trademark | No comments
Newer Post Older Post Home

0 comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Popular Posts

  • IPAB on Payyannur Ring
    [*S lightly long post] Background: The Intellectual Property Appellate Board (“ IPAB ”), in its recent order in SubhashJewellery v. Payyan...
  • Guest Post: Intermediary liability in defamation cases - Parle, Mouthshut & Visakha cases to clarify the law
    Chaitanya Ramachandran, who has blogged for us previously over here and here , has sent us this excellent guest post analyzing the extent of...
  • Delhi HC rejects the "Hot News" Doctrine: A Summary
    The applicability of the Hot News doctrine was rejected recently in a landmark ruling delivered by Justice Bhat of the Delhi HC. This post i...
  • IP Research Assistant position at IIT, Madras
    Feroz Ali Khader, MHRD IP Chair at the Indian Institute of Technology (IIT) Madras, is looking for research assistants to work on various is...
  • Satyajit Ray's sketches and copyright controversies
    A copyright row appears to have started between the Satyajit Ray Society and the Delhi Art Gallery, that is organising a countrywide exhibit...
  • Dorling Kindersley v. Sanguine Technical Publishers
    A recent Delhi High Court order passed on 21 January, 2013  with respect to copyright licensing has come to our notice. An analysis of the j...
  • Call for Papers: IIT Bombay and MHRD jointly announce the 2nd International Conference on Management of Intellectual Property and Strategy
    The readers may be interested to know that the Shailesh J. Mehta School of Management of IIT Bombay is geared up to host, in collaboration w...
  • SpicyIP Tidbit: ALCS August Distribution
    In the UK, the Authors' Licensing and Collecting Society is an organization run and owned by writers that collects money due to its mem...
  • Aaron Swartz, RIP
    See Cory Doctorow's eulogy here Some of us in India may not have heard of Aaron Swartz, a 26 year old activist who was heavily involved ...
  • Thalappakatti biryani trademark row
    The southern district of Dindigal in Tamil Nadu occupies a special place in the hearts of biryani lovers. In the late 1950s, one Nagasamy N...

Categories

  • 126 (1)
  • 3(d) (4)
  • 3(f) (1)
  • 3(i) (1)
  • 3(k) (2)
  • Academic Writing (1)
  • access (10)
  • access to food (1)
  • access to health (3)
  • AIA (1)
  • AIDS/HIV (3)
  • Antitrust (2)
  • Bajaj v LML (1)
  • Basmati Row (2)
  • Biological Diversity (5)
  • Biologics (2)
  • biopiracy (4)
  • biotech (7)
  • Bollywood (25)
  • Broadcasters Rights (5)
  • Budget (1)
  • business method patent (2)
  • Call for papers (2)
  • Cipla (2)
  • Comparative Advertising (4)
  • Competition law (8)
  • Compulsory Licensing (27)
  • condonation of delay (1)
  • Conference (4)
  • Constitution (12)
  • Contracts (1)
  • Controller's decisions (8)
  • Copyright (112)
  • Copyright Amendment Bill 2010 (23)
  • copyright board (4)
  • Copyright Exceptions (6)
  • copyright office (1)
  • Copyright Rules (2013) (5)
  • Copyright Societies (9)
  • Counterfeiting (1)
  • creativity (1)
  • Cross Retaliation (1)
  • csir (4)
  • d (1)
  • D.U. Photocopy Case (16)
  • Darjeeling Tea (3)
  • Data Exclusivity (2)
  • Database (1)
  • DCGI (2)
  • decompilation (2)
  • defamation (9)
  • Designs (3)
  • Designs Act (3)
  • Differential Pricing (2)
  • Dilution (1)
  • Disabilities (3)
  • Disability (2)
  • DMCA (2)
  • Doha Declaration (1)
  • Domain Names (2)
  • Draft Policy of the Indian Government (2)
  • DRM (1)
  • Drug Regulation (7)
  • education (12)
  • Enercon (1)
  • Enforcement (1)
  • EU (2)
  • ex parte (2)
  • exhaustion (3)
  • Exhaustion of Rights (2)
  • Fair Dealing (8)
  • Fair Use (11)
  • Federal Circuit (1)
  • Fees (3)
  • FICCI (7)
  • FRAND (2)
  • free trade agreement (3)
  • FTA (3)
  • G.I. Registry (4)
  • gene sequences (3)
  • Generic medicine (4)
  • Geographical Indication (14)
  • Gilead (1)
  • Glenmark (5)
  • Gopika (34)
  • Guest post (11)
  • guidelines (1)
  • GWU-CII (1)
  • Herceptin (1)
  • hot news (3)
  • ICANN (1)
  • incremental innovation (1)
  • independence (1)
  • india (5)
  • Indian Government (1)
  • Indian patent litigation (27)
  • Indian Pharma (35)
  • Injunction (10)
  • Innovation (7)
  • INTA (1)
  • Intermediaries (10)
  • internet (11)
  • Internet Access Providers (IAPs) (5)
  • Internet Censorship (7)
  • IP scholarship (3)
  • IP aware (4)
  • IP Course (3)
  • IP Education (1)
  • IP Policy (11)
  • IP update (4)
  • ip writing competition (1)
  • IPAB (34)
  • ipchair (1)
  • IPO (1)
  • IPRS (5)
  • IT Act (1)
  • Journal (2)
  • judicial independence (3)
  • Jurisdiction (1)
  • Kruttika (4)
  • Legal Education (3)
  • Legal Research Tools (1)
  • Legal Scholarship (2)
  • library (2)
  • Licensing (7)
  • Madhulika (20)
  • mathematical methods (1)
  • Media law (3)
  • medical method (1)
  • Merck (4)
  • mhrd ip chair (1)
  • Microsoft (3)
  • Middle Path (1)
  • Moral Rights (2)
  • Movies (18)
  • musical work (2)
  • nanotechnology (1)
  • Natco (3)
  • natco defamation suit (5)
  • natco vs bayer (4)
  • need for transparency (1)
  • Novartis (8)
  • Novartis patent case in India (11)
  • NPEs (2)
  • nujs (1)
  • NUJS Conference (2)
  • Obituary (1)
  • obviousness (7)
  • Off-Topic (2)
  • online course (4)
  • Open Access (6)
  • Open Source (2)
  • Opposition (3)
  • Parallel Imports (4)
  • Parliament (1)
  • passing off (5)
  • Patent (52)
  • Patent act (10)
  • patent agent (5)
  • patent agent exam (9)
  • patent agent exam qualifications (3)
  • patent infringement (5)
  • Patent Licensing (2)
  • Patent litigation (2)
  • Patent Office (19)
  • patent pool (3)
  • Patent Prosecution (7)
  • Patent rules (2)
  • Patent Strategies (8)
  • Patents (9)
  • pegasus (1)
  • Personality Rights (1)
  • Pfizer (1)
  • Pharma (18)
  • Piracy (5)
  • plagiarism (3)
  • Plant Variety Protection (2)
  • post grant (1)
  • Prashant (2)
  • Preventive Detention (1)
  • Price Control (6)
  • prior publication (1)
  • Privacy (3)
  • Prizes (1)
  • public health (3)
  • Public Interest (4)
  • Publicity Rights (4)
  • Publishing (3)
  • radio (2)
  • Rajiv (18)
  • Rectification Petition (2)
  • Rejection (1)
  • research (3)
  • reverse engineering (2)
  • revocation (4)
  • rip (1)
  • Roche (2)
  • Roche vs Cipla (1)
  • Royalty (2)
  • RTI (2)
  • Scholarship (4)
  • section 16 (1)
  • Section 3(d) (7)
  • section 8 (6)
  • shamnad (11)
  • Shan Kohli (4)
  • Shouvik Kumar Guha (30)
  • Smartphones/Tablets (2)
  • Social Innovation (1)
  • Software (10)
  • software enforcement (3)
  • software patent (3)
  • Special 301 Report (1)
  • Spicy Tidbits (6)
  • spicyip (1)
  • SpicyIP Accolades (1)
  • SpicyIP Announcements (9)
  • SpicyIP Case (1)
  • SpicyIP Cases (3)
  • spicyip commiseration (1)
  • SpicyIP Events (11)
  • SpicyIP Fellowship (5)
  • SpicyIP Guest Series (22)
  • SpicyIP Interview (2)
  • SpicyIP Jobs (4)
  • SpicyIP Jobs/General (2)
  • SpicyIP Review (1)
  • SpicyIP Tidbits (11)
  • SpicyIP Weekly Review (27)
  • Statutory Licensing (1)
  • STI Policy 2013 (4)
  • Sugen (3)
  • Supreme Court of India (5)
  • Swaraj (19)
  • Tarnishment (1)
  • Technology (6)
  • Technology Transfer (5)
  • TKDL (5)
  • TPP (1)
  • trade (4)
  • Trade Secret Protection (1)
  • Trademark (59)
  • Trademark dilution (1)
  • Trademark Registry (9)
  • Traditional Knowledge (7)
  • Transparency (5)
  • treaty (1)
  • trial (1)
  • tribunals (2)
  • TRIPS (11)
  • UK (3)
  • unfair competition (5)
  • UNFCCC (1)
  • Universities Research and Innovation Bill (2)
  • US (1)
  • US Patent Reform (1)
  • US Supreme Court (3)
  • viva (3)
  • WIPO (5)
  • Working a Patent (2)
  • Workshop (4)
  • writ (1)
  • WTO (1)

Blog Archive

  • ▼  2013 (364)
    • ►  September (13)
    • ►  August (41)
    • ►  July (36)
    • ►  June (36)
    • ▼  May (32)
      • Haldiram Bhujiawala: IPAB Order
      • Guest Post: Impugning novelty the Novartis way
      • Comparative Advertising: Reckitt Benckiser trumps ...
      • The (Great) Gatsby Files: IPAB decides in favour o...
      • SpicyIP Weekly Review (May 4th Week)
      • Comparative Advertising: Delhi HC (Reckitt Benckis...
      • Drug price control order (DPCO) 2013 : What's in s...
      • Micolube: Dual Protection and the Doctrine of Elec...
      • SpicyIP Tidbit: IPXI releases latest edition of i...
      • The Times Publishing House threatens to sue our bl...
      • Microsoft v. Motorola: A FRAND-ly formula for fixi...
      • Guest Post: A rejoinder from the IPKat
      • WIPS (Worldwide Intellectual Property Service) – I...
      • The curious case of medical method patent: Can doc...
      • Guest Post: A response to the IPKat's "despair" by...
      • Javed Akhtar nominated for CISAC Vice-Presidency
      • Guest Post: A quick update on Viacom v. YouTube
      • Guest post: Avoiding Open Source Surprises When Bu...
      • Guest Post: The IPKat's "despair" with the Supreme...
      • Comparative Advertising: Delhi HC (SAFFOLA v. FORT...
      • SpicyIP Events: Registrations for Consilience 2013...
      • IPAB upholds validity of Bajaj Auto's patent in re...
      • SpicyIP Tidbit: Update on Zanjeer and Bombay Talkies
      • The Ericsson-Micromax patent litigation: Where is ...
      • SpicyIP Weekly Review (May 2013, Week 1)
      • The Jaguar Trademark Conundrum
      • Social Innovations: A Braille Smartphone
      • USTR's Special 301 Process 2013 - India on Priorit...
      • The constitutional challenge by film producers to ...
      • FICCI announces online certificate course on compe...
      • Justice Sridevan’s status report to the Madras Hig...
      • Job openings at the Vidhi Centre for Legal Policy
    • ►  April (51)
    • ►  March (66)
    • ►  February (40)
    • ►  January (49)
  • ►  2012 (131)
    • ►  December (29)
    • ►  November (42)
    • ►  October (50)
    • ►  September (10)
Powered by Blogger.